Investor Presentaiton

"Type 1 Use Regulations" and "Biological Diversity Risk Assessment Report" II. Information concerning preparation of living modified organisms 4. State of existence of nucleic acid transferred to cells and stability of expression of traits caused by the nucleic acid 5. Methods of detection and identification of living modified organisms and their sensitivity and reliability 6. Difference from the recipient organism or the taxonomical species to which the recipient organism belongs

View entire presentation